279 related articles for article (PubMed ID: 37007117)
1. A comprehensive overview of exosome lncRNAs: Emerging biomarkers and potential therapeutics in gynecological cancers.
Wang M; Fu L; Xu Y; Ma S; Zhang X; Zheng L
Front Oncol; 2023; 13():1138142. PubMed ID: 37007117
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis.
Wang M; Zheng L; Lin R; Ma S; Li J; Yang S
Front Endocrinol (Lausanne); 2023; 14():1199569. PubMed ID: 37455911
[TBL] [Abstract][Full Text] [Related]
3. Biogenesis and function of exosome lncRNAs and their role in female pathological pregnancy.
Wang M; Zheng L; Ma S; Lin R; Li J; Yang S
Front Endocrinol (Lausanne); 2023; 14():1191721. PubMed ID: 37745705
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
5. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer.
Qiu P; Guo Q; Lin J; Pan K; Chen J; Ding M
Sci Rep; 2022 Dec; 12(1):22322. PubMed ID: 36566321
[TBL] [Abstract][Full Text] [Related]
6. Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects.
Qiao FH; Tu M; Liu HY
Oncol Lett; 2021 Apr; 21(4):333. PubMed ID: 33692865
[TBL] [Abstract][Full Text] [Related]
7. LncRNAs: key players and novel insights into cervical cancer.
Peng L; Yuan X; Jiang B; Tang Z; Li GC
Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
[TBL] [Abstract][Full Text] [Related]
8. LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy.
Ray SK; Mukherjee S
Curr Cancer Drug Targets; 2021; 21(5):416-427. PubMed ID: 33413062
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature.
Ding H; Jiang F; Deng L; Wang J; Wang P; Ji M; Li J; Shi W; Pei Y; Li J; Zhang Y; Zhang Z; Chen Y; Li B
Front Cell Dev Biol; 2021; 9():814456. PubMed ID: 35178403
[TBL] [Abstract][Full Text] [Related]
10. An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma.
Peng W; Bai S; Zheng M; Chen W; Li Y; Yang Y; Zhao Y; Xiong S; Wang R; Cheng B
Transl Oncol; 2023 May; 31():101651. PubMed ID: 36933293
[TBL] [Abstract][Full Text] [Related]
11. Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural compounds.
Li Y; Zhang C; Feng L; Shen Q; Liu F; Jiang X; Pang B
Front Pharmacol; 2023; 14():1195104. PubMed ID: 37383719
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive
Wang Z; Ji X; Gao L; Guo X; Lian W; Deng K; Xing B
Front Oncol; 2021; 11():553594. PubMed ID: 33747903
[TBL] [Abstract][Full Text] [Related]
13. Exosome-Derived LncRNAs in Lung Cancer.
Fan T; Sun N; He J
Front Oncol; 2020; 10():1728. PubMed ID: 33072553
[TBL] [Abstract][Full Text] [Related]
14. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
[TBL] [Abstract][Full Text] [Related]
16. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.
Guo Q; Cheng Y; Liang T; He Y; Ren C; Sun L; Zhang G
Sci Rep; 2015 Dec; 5():17683. PubMed ID: 26631459
[TBL] [Abstract][Full Text] [Related]
18. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Role and Clinical Applications of Exosomes in Gynecologic Malignancies: A Review of the Current Literature.
Roy M; Yang YP; Bosquet O; Deo SK; Daunert S
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008322
[TBL] [Abstract][Full Text] [Related]
20. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
